TissueForm
Company

Last deal

$250.K

Amount

Grant

Stage

18.05.2023

Date

1

all rounds

$250.K

Total amount

General

About Company
TissueForm creates biomaterials for implantable medical devices to help patients suffering from tissue loss.

Industry

Sector :

Subsector :

Keywords :

founded date

01.03.2019

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

The company uses a platform technology to mimic body tissues and create biomaterials that encourage the patient's own cells to promote healing and repair. Their products include a dermal filler material, a material for 3D bioprinting, and a material for articular cartilage repair. The biomaterials are made of cross-linkable tissue and protein components that mimic natural tissue, and maintain tissue-specific growth factors. They are easy to form and integrate upon delivery to the patient, and are cost-effective to produce.
Contacts